Riskpilot← Back to searchSign inGet full accessEVOLVA BIOTECH A/S
A/SIn liquidationCVR 25532538Fruebjergvej 3Forskning og eksperimentel udvikling indenfor bioteknologi · NACE 721100Est. 20001 employees
Revenue 2020
DKK -116K
-118% vs 2019
EBITDA margin
100.2%
+42% vs 2019
Equity ratio
98.3%
Financial strength
Net profit 2020
DKK -197K
-5% vs 2019
| Revenue | DKK -116K | -118% |
| EBITDA | DKK -116K | +42% |
| Net profit | DKK -197K | -5% |
| Total assets | DKK 6,5M | -1% |
| Equity | DKK 6,4M | -3% |
| Employees | 1 | — |
Legal name
EVOLVA BIOTECH A/S
CVR number
25532538
Legal form
Aktieselskab
NACE code
721100 · Forskning og eksperimentel udvikling indenfor bioteknologi
Founded
17. juli 2000
Share capital
DKK 4.311.583
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2020-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Address
Fruebjergvej 3
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 19.096 | 26.988 | 39.428 | 47.695 | 59.908 | 69.885 | 2.917 | 639 | -116 |
| Staff expenses | -12.710 | -17.442 | -23.907 | -27.719 | -35.986 | -39.390 | -2.808 | -839 | -0 |
| EBITDA | -62 | 1.449 | 4.498 | 4.565 | 5.890 | 5.991 | 110 | -200 | -116 |
| Depreciation & amort. | -1.753 | -2.159 | -2.870 | -4.554 | -5.708 | -5.804 | -0 | -0 | -0 |
| EBIT | -1.815 | -710 | 1.628 | 10 | 182 | 187 | 110 | -200 | -116 |
| Net financials | -164 | -75 | 200 | -1.062 | -802 | -912 | 131 | 13 | -80 |
| Profit before tax | -1.978 | -1.156 | 1.828 | -1.052 | -620 | -725 | 241 | -187 | -197 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | -1.978 | -1.156 | 1.828 | -1.052 | -620 | -725 | 241 | -187 | -197 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 32.087 | 81.901 | 29.274 | 42.138 | 31.564 | 21.049 | 8.057 | 6.578 | 6.486 |
| Equity | 8.244 | 7.088 | 8.917 | 7.865 | 7.246 | 6.521 | 6.762 | 6.575 | 6.379 |
| Long-term debt | 18.711 | 68.604 | 13.349 | 24.707 | 15.067 | 0 | 987 | 0 | 0 |
| Short-term debt | 5.132 | 6.209 | 7.009 | 9.566 | 9.251 | 14.528 | 1.295 | 2 | 107 |
| Total debt | 23.843 | 74.813 | 20.358 | 34.273 | 24.318 | 14.528 | 1.295 | 2 | 107 |
EBITDA margin
-11643200.0%
This company
15.8%
Market median
-73691239% vs market
20122020
Equity ratio
98.3%
This company
38.2%
Market median
+157% vs market
20122020
Return on equity
-3.1%
This company
18.4%
Market median
-117% vs market
20122020
Net profit margin
-19680600.0%
This company
8.1%
Market median
-242970470% vs market
20122020
Asset turnover
-0.02×
This company
1.12×
Market median
-102% vs market
20122020
Debt / equity
0.02×
This company
0.62×
Market median
+97% vs market
20122020
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MB Chief Executive Officer | Chief Executive Officer | 2003 | — | — |
CD Unofficial title | Unofficial title | 2021 | — | — |
AM Management | Management | 2017 | — | — |
MB Management | Management | 2010 | — | — |
HW Chief Executive Officer | Chief Executive Officer | 2008 | — | — |
KI Chief Executive Officer | Chief Executive Officer | 2004 | — | — |
JH Management | Management | 2013 | — | — |
KS Management | Management | 2000 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2000 | — | — | |
| Board of Directors | 2000 | — | — | |
| Board of Directors | 2007 | — | — | |
| Chairman | 2017 | — | — | |
| Board of Directors | 2010 | — | — | |
| Board of Directors | 2009 | — | — | |
| Board of Directors | 2011 | — | — | |
| Chairman | 2010 | — | — | |
| Board of Directors | 2001 | — | — | |
| Chairman | 2000 | — | — | |
| Board of Directors | 2010 | — | — | |
| Board of Directors | 2014 | — | — | |
| Board of Directors | 2002 | — | — | |
| Board of Directors | 2004 | — | — | |
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2000 | — | — | |
| Board of Directors | 2009 | — | — | |
| Board of Directors | 2005 | — | — | |
| Chairman | 2000 | — | — | |
| Board of Directors | 2005 | — | — | |
| Board of Directors | 2000 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2000 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of EVOLVA BIOTECH A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Martin Bonde | Chief Executive Officer | 0 companies |
| Carsten Däweritz | Unofficial title | 0 companies |
| Alessandro Mauro Del Fabro | Management | 0 companies |
| Martin Bo Pedersen | Management | 0 companies |
| Harry Welten | Chief Executive Officer | 0 companies |
| Khalid Islam | Chief Executive Officer | 0 companies |
| Jørgen Hansen | Management | 0 companies |
| Kjell Stenberg | Management | 0 companies |
| Søren Knud Carlsen | Board of Directors | 0 companies |
| Claus Tycho Bræstrup | Board of Directors | 0 companies |
| Paul Hadvary | Board of Directors | 0 companies |
| Oliver Patrick Walker | Chairman | 0 companies |
| Peter Bisgaard | Board of Directors | 0 companies |
| Jürgen Julius Otto Raths | Board of Directors | 0 companies |
| Jutta Monika Heim | Board of Directors | 0 companies |
| Jakob Dynnes Hansen | Chairman | 0 companies |
| Peter Bent Svejgaard Kristensen | Board of Directors | 0 companies |
| Klaus Bock | Chairman | 0 companies |
| Neil Goldsmith | Board of Directors | 0 companies |
| Bo Danner Henriksen | Board of Directors | 0 companies |
| Martin Olin | Board of Directors | 0 companies |
| Khalid Islam | Board of Directors | 0 companies |
| Nic Bürgin | Board of Directors | 0 companies |
| Anna Helena Elisabeth Brounéus | Board of Directors | 0 companies |
| Markus Peter Steiger | Board of Directors | 0 companies |
| Dieter Gillessen | Board of Directors | 0 companies |
| Søren Mouritsen | Chairman | 0 companies |
| Sergio Lociuro | Board of Directors | 0 companies |
| Arne Gillin | Board of Directors | 0 companies |